These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 26601990)

  • 21. Discovery and validation of molecular biomarkers for colorectal adenomas and cancer with application to blood testing.
    LaPointe LC; Pedersen SK; Dunne R; Brown GS; Pimlott L; Gaur S; McEvoy A; Thomas M; Wattchow D; Molloy PL; Young GP
    PLoS One; 2012; 7(1):e29059. PubMed ID: 22276102
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma levels of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-1 correlate with disease stage and survival in colorectal cancer patients.
    Waas ET; Hendriks T; Lomme RM; Wobbes T
    Dis Colon Rectum; 2005 Apr; 48(4):700-10. PubMed ID: 15906450
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum matrix metalloproteinase-9 in colorectal cancer family-risk population screening.
    Otero-Estévez O; De Chiara L; Rodríguez-Girondo M; Rodríguez-Berrocal FJ; Cubiella J; Castro I; Hernández V; Martínez-Zorzano VS
    Sci Rep; 2015 Aug; 5():13030. PubMed ID: 26264519
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Profiling tumor-associated markers for early detection of malignant mesothelioma: an epidemiologic study.
    Amati M; Tomasetti M; Scartozzi M; Mariotti L; Alleva R; Pignotti E; Borghi B; Valentino M; Governa M; Neuzil J; Santarelli L
    Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):163-70. PubMed ID: 18199721
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictive cytogenetic biomarkers for colorectal neoplasia in medium risk patients.
    Ionescu EM; Nicolaie T; Ionescu MA; Becheanu G; Andrei F; Diculescu M; Ciocirlan M
    J Med Life; 2015; 8(3):398-403. PubMed ID: 26351547
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circulating gelatinases and tissue inhibitor of metalloproteinase-1 in colorectal cancer metastatic liver disease.
    Waas ET; Wobbes T; Ruers T; Lomme RM; Hendriks T
    Eur J Surg Oncol; 2006 Sep; 32(7):756-63. PubMed ID: 16650961
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum CD26 is related to histopathological polyp traits and behaves as a marker for colorectal cancer and advanced adenomas.
    De Chiara L; Rodríguez-Piñeiro AM; Rodríguez-Berrocal FJ; Cordero OJ; Martínez-Ares D; Páez de la Cadena M
    BMC Cancer; 2010 Jun; 10():333. PubMed ID: 20584285
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Matrix metalloproteinase (MMP) -2, -7 and -9 promoter polymorphisms in colorectal cancer in ethnic Kashmiri population - A case-control study and a mini review.
    Banday MZ; Sameer AS; Mir AH; Mokhdomi TA; Chowdri NA; Haq E
    Gene; 2016 Sep; 589(1):81-89. PubMed ID: 27222481
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum angiogenin as a potential biomarker for early detection of colorectal adenomas and colorectal cancer.
    Yu D; Sun J; Weng Y; Luo L; Sheng J; Xu Z
    Anticancer Drugs; 2021 Aug; 32(7):703-708. PubMed ID: 33661188
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of large serrated polyps with synchronous advanced colorectal neoplasia.
    Li D; Jin C; McCulloch C; Kakar S; Berger BM; Imperiale TF; Terdiman JP
    Am J Gastroenterol; 2009 Mar; 104(3):695-702. PubMed ID: 19223889
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlation between matrix metalloproteinase 9 and 18F-2-fluoro-2-deoxyglucose-positron emission tomography as diagnostic markers of lung cancer.
    Fiorelli A; Rizzo A; Messina G; Izzo A; Vicidomini G; Pannone G; Santini M; Di Domenico M
    Eur J Cardiothorac Surg; 2012 Apr; 41(4):852-60. PubMed ID: 22219420
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MMP, VEGF and TIMP as prognostic factors in recurring bladder cancer.
    Wieczorek E; Jablonowski Z; Tomasik B; Konecki T; Jablonska E; Gromadzinska J; Fendler W; Sosnowski M; Wasowicz W; Reszka E
    Clin Biochem; 2015 Dec; 48(18):1235-40. PubMed ID: 26197083
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum levels of matrix metalloproteinase-2 and -9 and conventional tumor markers (CEA and CA 19-9) in patients with colorectal and gastric cancers.
    Emara M; Cheung PY; Grabowski K; Sawicki G; Wozniak M
    Clin Chem Lab Med; 2009; 47(8):993-1000. PubMed ID: 19569980
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Factors related to advanced colorectal neoplasm at the Policlínico Peruano Japonés.
    Parra-Pérez V; Watanabe-Yamamoto J; Nago-Nago A; Astete-Benavides M; Rodríguez-Ulloa C; Valladares-Álvarez G; Núñez-Calixto N; Yoza-Yoshidaira M; Gargurevich-Sánchez T; Pinto-Sánchez J; Niebuhr-Kakiuchi J; Uehara-Miyagusuku G; Rodríguez-Grandez J; Komazona-Sugajara R; Gutiérrez de Aranguren CF
    Rev Gastroenterol Mex; 2015; 80(4):239-47. PubMed ID: 26253888
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A case-control study of pre-operative levels of serum neutrophil gelatinase-associated lipocalin and other potential inflammatory markers in colorectal cancer.
    Duvillard L; Ortega-Deballon P; Bourredjem A; Scherrer ML; Mantion G; Delhorme JB; Deguelte-Lardière S; Petit JM; Bonithon-Kopp C;
    BMC Cancer; 2014 Dec; 14():912. PubMed ID: 25472811
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The evaluation of diagnostic value of the tumor markers: CCSA-2 and CEA in colorectal cancer.
    Knychalski B; Lukieńczuk T
    Pol Przegl Chir; 2012 Feb; 84(2):86-92. PubMed ID: 22487741
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Progressive increase of matrix metalloprotease-9 and interleukin-8 serum levels during carcinogenic process in human colorectal tract.
    Biasi F; Guina T; Maina M; Nano M; Falcone A; Aroasio E; Saracco GM; Papotti M; Leonarduzzi G; Poli G
    PLoS One; 2012; 7(7):e41839. PubMed ID: 22848630
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma MMP2/TIMP4 Ratio at Follow-up Assessment Predicts Disease Progression of Idiopathic Pulmonary Arterial Hypertension.
    Wetzl V; Tiede SL; Faerber L; Weissmann N; Schermuly RT; Ghofrani HA; Gall H
    Lung; 2017 Aug; 195(4):489-496. PubMed ID: 28516393
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Insulin-like growth factor-I and insulin are associated with the presence and advancement of adenomatous polyps.
    Schoen RE; Weissfeld JL; Kuller LH; Thaete FL; Evans RW; Hayes RB; Rosen CJ
    Gastroenterology; 2005 Aug; 129(2):464-75. PubMed ID: 16083703
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Elevated ratio of MMP2/MMP9 activity is associated with poor response to chemotherapy in osteosarcoma.
    Kunz P; Sähr H; Lehner B; Fischer C; Seebach E; Fellenberg J
    BMC Cancer; 2016 Mar; 16():223. PubMed ID: 26979530
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.